Harvard Bioscience Inc (HBIO)

Listed in the US · Manufacturing · Laboratory analytical instruments

$8.80

As of 29 Oct 2026 close.

Facts from reported results and exchange filings. Not investment advice.

Share price

Prices load here as you scroll to them.

Last close $8.80 on 29 Oct 2026. The share price traded between $4.00 and $9.40 (intraday) over the last 12 months.

The closes as a table

DateClose

Key figures

1-year range (intraday)

Last close $8.80

Low $4.00High $9.40

Market cap$390Mlast close × shares
Net profit−$10.41Mlast 12 months
Return on equity−413.0%year to Dec 2025
EBITDA margin−54.1%year to Dec 2025
Debt to equity2.61year to Dec 2025
Net margin−65.5%year to Dec 2025
Dividend yieldnonelast 12 months

P/E isn't shown: the company made a loss over the last 12 months, and a loss has no P/E.

Price trend

Revenue and profit

RevenueNet profit$ million
-100-50050100150
YearDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue1191131129487
Net profit-0.29-10-3-12-57
EBITDA margin3.2%-4.8%3.0%-4.8%-54.1%
Borrowings4847373736

$ million. Over three years, compounded: revenue fell 8.6% a year.

Recent filings

Questions about Harvard Bioscience Inc

What is Harvard Bioscience Inc's market value?

Harvard Bioscience Inc's market value is $390M as of 29 Oct 2026 close: the last close times the shares in issue.

Go further with HBIO

Free to start: test a trading idea on HBIO's real prices after costs, or open the full deep dive with ten years of numbers, red flags and management's record.

Same industry

The largest companies in the same industry (Laboratory analytical instruments), by market value.

Browse companies

The companies before and after this one, A to Z, and the lists it is in.

How these figures are worked out

The net profit for the last 12 months is the four latest reported quarters, so it can differ from the newest year's in the table below.